AU4399296A - A combination product comprising nitazoxanide and an anti-ulcer agent - Google Patents

A combination product comprising nitazoxanide and an anti-ulcer agent

Info

Publication number
AU4399296A
AU4399296A AU43992/96A AU4399296A AU4399296A AU 4399296 A AU4399296 A AU 4399296A AU 43992/96 A AU43992/96 A AU 43992/96A AU 4399296 A AU4399296 A AU 4399296A AU 4399296 A AU4399296 A AU 4399296A
Authority
AU
Australia
Prior art keywords
nitazoxanide
combination product
ulcer agent
ulcer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43992/96A
Inventor
Aggelos Nikolopoulos
Helmut Schickaneder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAUTERAL Ltd
Original Assignee
LAUTERAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE950090A external-priority patent/IE950090A1/en
Application filed by LAUTERAL Ltd filed Critical LAUTERAL Ltd
Publication of AU4399296A publication Critical patent/AU4399296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
AU43992/96A 1994-12-19 1995-12-19 A combination product comprising nitazoxanide and an anti-ulcer agent Abandoned AU4399296A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IE940972 1994-12-19
IE940972 1994-12-19
IE950090 1995-02-06
IE950090A IE950090A1 (en) 1995-02-06 1995-02-06 Pharmaceutical composition
IE950149 1995-02-23
IE950149 1995-02-23
PCT/IE1995/000064 WO1996019220A1 (en) 1994-12-19 1995-12-19 A combination product comprising nitazoxanide and an anti-ulcer agent

Publications (1)

Publication Number Publication Date
AU4399296A true AU4399296A (en) 1996-07-10

Family

ID=27270487

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43992/96A Abandoned AU4399296A (en) 1994-12-19 1995-12-19 A combination product comprising nitazoxanide and an anti-ulcer agent

Country Status (2)

Country Link
AU (1) AU4399296A (en)
WO (1) WO1996019220A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101217415B1 (en) * 2007-04-02 2013-01-02 사이더로믹스, 엘엘씨 Methods for preventing or treating infectious diseases using gallium compounds
BR112017004889A2 (en) 2014-09-12 2017-12-05 Antibiotx Aps antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR20190122806A (en) * 2017-03-13 2019-10-30 장피트 Pharmaceutical Compositions for Combination Therapy
WO2020176067A1 (en) * 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052698A1 (en) * 1990-10-11 1992-04-12 Roger G. Berlin Treatment of peptic ulcer
DE4317449A1 (en) * 1993-05-19 1994-11-24 Asche Ag Pharmaceutical composition for the treatment of disorders of the gastrointestinal tract

Also Published As

Publication number Publication date
WO1996019220A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
AU698398B2 (en) Ultrasonic processes and circuits for carrying out those processes
AU3793095A (en) Bag for bag-in-box and bag-in-box
EP0690039A3 (en) Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
AU3532195A (en) Medicaments
AU3731995A (en) Hypoglycemic agent from cryptolepis
AU8865098A (en) A composition and a product containing the same
EP0690494A3 (en) Connection and build-up-process for multi-chip-modules
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU2782595A (en) Non-silicated soft metal safe product
AU1642395A (en) Alpha-aminoalkanoic acids and reduction products
AU4723196A (en) Releasable coupling and tool therefor
AU3016495A (en) Sealed article
AU3077595A (en) Cleaning product and related packaging
AU5509294A (en) Antidiabetic agent
AU2148395A (en) Joiner and liner strip
AU6995594A (en) Aryltriflates and related compounds
AU697648B2 (en) 2-arylpyrimidines and herbicidal use thereof
AU4122196A (en) Sealing article
AU4399296A (en) A combination product comprising nitazoxanide and an anti-ulcer agent
AU6544294A (en) Polystyrene-dissolving agent
AU3634595A (en) Bis-oxazolidines and their use
AU6809594A (en) Colletotrichum and use thereof
AU3479495A (en) Alpha-1-antitrypsin and antithrombine-iii variants
AU6892394A (en) Insulative materials and products
AU5188296A (en) Carbopeptoids and carbonucleotoids